Syros Pharmaceuticals, Inc. - common stock (SYRS): Price and Financial Metrics
Syros Pharmaceuticals, Inc. - common stock (SYRS)
Today's Latest Price: $7.68 USD
0.19 (-2.41%)
Updated Feb 18 8:00pm
Add SYRS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
SYRS Stock Summary
- With a price/sales ratio of 164.78, Syros Pharmaceuticals Inc has a higher such ratio than 98.4% of stocks in our set.
- With a year-over-year growth in debt of 64,390.91%, Syros Pharmaceuticals Inc's debt growth rate surpasses 99.88% of about US stocks.
- Revenue growth over the past 12 months for Syros Pharmaceuticals Inc comes in at 104.58%, a number that bests 94.58% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Syros Pharmaceuticals Inc are BPMC, ESPR, SYBX, FATE, and VNE.
- Visit SYRS's SEC page to see the company's official filings. To visit the company's web site, go to www.syros.com.
SYRS Daily Price Range
SYRS 52-Week Price Range
SYRS Stock Price Chart More Charts
SYRS Price/Volume Stats
| Current price | $7.68 | 52-week high | $11.93 |
| Prev. close | $7.87 | 52-week low | $4.45 |
| Day low | $7.22 | Volume | 176,600 |
| Day high | $7.85 | Avg. volume | 247,519 |
| 50-day MA | $6.96 | Dividend yield | N/A |
| 200-day MA | $7.52 | Market Cap | 325.95M |
Syros Pharmaceuticals, Inc. - common stock (SYRS) Company Bio
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts.
Top Stories View All
Best & Worst Performing Stock Industries for February 18, 2020
Best & Worst Performing Small Cap Stocks for February 18, 2020
Best & Worst Performing Mid Cap Stocks for February 18, 2020
Best & Worst Performing Large Cap Stocks for February 18, 2020
Best & Worst Performing Mega Cap Stocks for February 18, 2020
View All Top Stories
Loading social stream, please wait...